Insulin Resistance Increases Risk for Alzheimer's Disease
Insulin resistance, broadly defined as reduced tissue responsiveness to the action of insulin, is common in people who are obese, prediabetic or have Type 2 diabetes. Insulin has been increasingly recognised as playing an important role in the brain, according to the study background.
Barbara B. Bendlin, PhD, of the University of Wisconsin School of Medicine and Public Health, and colleagues examined 150 cognitively normal, late middle-age adults (average age nearly 61) from the Wisconsin Registry for Alzheimer’s Prevention (WRAP) study, a general community sample enriched for AD parental history. The subjects underwent cognitive testing, a fasting blood draw and fludeoxyglucose F 18-labelled positron emission tomography (PET) of the brain.
Of the 150 participants, 108 (72 percent) were women, 103 (68.7 percent) had a parental history of AD, 61 (40.7 percent) had an APOE ε4 allele and seven (4.7 percent) had type 2 diabetes.
Dr. Bendlin's team found that insulin resistance was associated with lower global glucose metabolism and lower regional glucose metabolism across large portions of the brain in the frontal, lateral, parietal, lateral temporal and medial temporal lobes. Lower glucose metabolism in the left medial temporal lobe was related to worse performance in immediate memory, according to researchers.
The study is the first to look at insulin resistance in late middle-aged people, identify a pattern of decreased blood sugar use related to AD and link that to memory decline.
“The prevalence of AD continues to grow, and midlife may be a critical period for initiating treatments aimed at preventing or delaying the onset of AD. Accumulating evidence suggests that treatments targeting mechanisms involved in insulin signalling may affect central glucose metabolism and should be investigated in the context of presymptomatic AD,” the authors conclude.
Image credit: Flickr.com
Published on : Tue, 28 Jul 2015
Print as PDF
The new 3Dimensions™ Mammography System matches the unrivaled performance of our 3D Mammography™ exam, which is more accurate than conventional 2D mammograms, detecting 20-65% more invasive breast cancers.Breakthrough improvements transform the patient...
The iViz is a lightweight Point Of Care (POC) ultrasound solution, specifically designed for emerging sub-segments where there is need for a highly accessible and mobile solution that is capable throughout key areas of the patient care path. The iViz...
Sectra offers solutions for capturing, storing and accessing virtually all images, video, audio and documents. Sectra VNA allows you to consolidate image handling, while ensuring clinical workflow efficiency, growth management and business continuity...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes X-Porte's...
Sectra's reporting module, developed with complex oncology cases in mind, facilitates overview of relevant priors together with the current request and report text. It also offers support for resident workflows and embedded links to images in the rep...